Please login to the form below

Not currently logged in
Email:
Password:

Allergan veteran joins Kala as head of business development

Charles McDermott has experience in ophthalmology

Kala Pharma Charles McDermott Charles McDermott, who has spent the last eight years at Allergan, has joined serious disease specialist Kala Pharmaceuticals as executive VP, business development.

McDermott was most recently VP, business development at Botox developers Allergan, and during his time at the company he completed several transaction and partnership agreements involving such products as eye inflammation treatments Acular and Acuvail, as well as Latisse to support the growth of eyelashes.

Prior to joining Allergan, McDermott spent several years at deCODE Genetics in several buinsess development positions.

He also has research experience, serving as a research scientist at Agouron Pharmaceuticals.

Kala will benefit from McDermott's experience in eye conditions as the company looks to advance its lead ophthalmic candidates towards clinical studies.

“We are rapidly gaining momentum within the ophthalmic industry and Charlie shares our vision to make a difference in the lives of patients suffering from ocular diseases,” said Dr Guillaume Pfefer, CEO of Kala.

“Based on his experience at Allergan, he fully appreciates the potential of Kala's mucosal penetrating product technology to transform clinical practice and to enable effective local treatments for serious diseases,” he added.

30th May 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...